E RANDERATH
Overview
Explore the profile of E RANDERATH including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
960
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
RANDERATH E
Virchows Arch Pathol Anat Physiol Klin Med
. 2010 Mar;
314(3-4):388-459.
PMID: 20270049
No abstract available.
3.
Zhou G, RANDERATH E, Randerath K
Mutat Res
. 2001 Jul;
479(1-2):71-9.
PMID: 11470482
Bulky endogenous oxidative lesions (type II I-compounds) reflect DNA damage associated with oxidative stress. As shown by 32P-postlabeling, their levels are enhanced by pro-oxidant genotoxins and also shortly after normal...
4.
Zhou G, Hernandez N, RANDERATH E, Randerath K
Mutat Res
. 2001 Feb;
447(2):137-47.
PMID: 10751597
Type II I-compounds (indigenous DNA adducts) denote a class of bulky oxidative DNA lesions that are detectable by 32P-postlabeling and represent useful biomarkers of DNA damage induced by oxidative stress....
5.
Zhou G, Hernandez N, RANDERATH E, Randerath K
Nutr Cancer
. 2000 Jan;
35(1):87-95.
PMID: 10624711
Type I I-compounds are bulky endogenous DNA modifications detectable by 32P postlabeling that exhibit age, species, tissue, genotype, gender, and diet dependence. Their formation appears unrelated to oxidative stress. In...
6.
Randerath K, RANDERATH E, Zhou G, Supunpong N, He L, McDonald T, et al.
Environ Mol Mutagen
. 1999 Jul;
33(4):303-12.
PMID: 10398378
Although human exposure generally occurs to mixtures of chemicals, limited toxicological information is available to characterize the potential interactions of the components of environmental mixtures. This study was conducted to...
7.
Randerath K, RANDERATH E, Zhou G, Li D
Mutat Res
. 1999 Mar;
424(1-2):183-94.
PMID: 10064860
I-compounds are bulky covalent DNA modifications which increase with age in tissues of unexposed laboratory animals and are derived from endogenous DNA-reactive intermediates of nutrient and oxygen metabolism. They have...
8.
Vulimiri S, Zhou G, Randerath K, RANDERATH E
Mutat Res
. 1998 Dec;
422(2):297-311.
PMID: 9838171
I (indigenous)-compounds are bulky endogenous DNA adducts which are detected by 32P-postlabeling in unexposed animals. I-compound levels in rodents depend on age, species, strain, gender, tissue, diet, and chemical exposure....
9.
Zhou G, Vulimiri S, RANDERATH E, Randerath K
Carcinogenesis
. 1998 Nov;
19(10):1863-6.
PMID: 9806170
I-compounds are endogenous bulky DNA modifications which are detected by nuclease P1-enhanced 32P-post-labeling in tissue DNA of animals not knowingly exposed to carcinogens. Their profiles and levels depend inter alia...
10.
Randerath K, Zhou G, Monk S, RANDERATH E
Carcinogenesis
. 1997 Jul;
18(7):1419-21.
PMID: 9230290
The purpose of this study was to determine whether the level of 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-hydroxy-2'-deoxyguanosine) (8-oxo-dG), a major mutagenic DNA oxidation product, is enhanced in newborn rat liver DNA as a...